99mTc-Functionalized Single-Walled Carbon Nanotubes for Bone Targeting
Source abstract
Abstract
Tailoring carbon nanotube surface chemistry is essential for biomedical applications. Bisphosphonate–carbon nanotube conjugates were prepared to target regions of active bone metabolism. The conjugates were synthesized using covalent functionalization (G1) or latently reactive polymer–nanotube complexes (G2), and it was found that the noncovalent G2 method afforded higher quality colloidal dispersions. The in vitro cytotoxicity tests against C2C12 cells were carried out and the results revealed low cytotoxicity and good biocompatibility profile for both bisphosphonate–carbon nanotube conjugates. The conjugates were radiolabeled with 99mTc in high radiochemical yield (80–92%). In vitro binding studies to hydroxyapatite showed binding of 77 and 36% for G1 and G2, respectively, after 1 h incubation at room temperature. A biodistribution study of G1 and G2 in vivo in a Balb/c mouse model demonstrated rapid blood clearance after 1 h and superior bone localization of G2 conjugates as compared to G1 conjugates. Photoacoustic imaging of nanotube conjugates confirmed superior in vivo bone localization of G2 as compared to G1. Together, biodistribution studies of radiolabeled complexes and photoacoustic imaging demonstrated that latently reactive polymer–nanotube complexes are a promising platform to modulate carbon nanotube surface chemistry for targeted diagnostic and drug delivery.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopedic Infections and Treatments · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario L8S 4M1, Canada
Biotechnology Program, Faculty of Health Sciences & Wellness, Humber College, Toronto, Ontario M9W 5L7, Canada
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095, United States
Funding
Canadian Institutes of Health Research · Canada Foundation for Innovation · Natural Sciences and Engineering Research Council of Canada
References (36)
Show source-provided references
1. 10.1371/journal.pone.017260110.1371/journal.pone.0172601 ↗
2. 10.1016/S1369-7021(11)70058-X10.1016/S1369-7021(11)70058-X ↗
3. 10.1016/s0142-9612(00)00121-610.1016/s0142-9612(00)00121-6 ↗
4. 10.1021/acs.macromol.8b0004910.1021/acs.macromol.8b00049 ↗
5. 10.1039/c8py00377g10.1039/c8py00377g ↗
6. 10.1039/c8py01003j10.1039/c8py01003j ↗
7. 10.1021/acsapm.9b0004010.1021/acsapm.9b00040 ↗
8. 10.1002/pola.2925610.1002/pola.29256 ↗
9. 10.1021/acsanm.9b0091210.1021/acsanm.9b00912 ↗
10. 10.1002/pola.2945410.1002/pola.29454 ↗
11. 10.1002/anie.20046043710.1002/anie.200460437 ↗
12. 10.1002/jbm.a.3295810.1002/jbm.a.32958 ↗
13. 10.1016/j.biomaterials.2006.09.01310.1016/j.biomaterials.2006.09.013 ↗
14. 10.1021/la903472210.1021/la9034722 ↗
15. 10.1002/smll.20070067010.1002/smll.200700670 ↗
16. 10.2174/09298670878350314010.2174/092986708783503140 ↗
17. 10.1166/jbn.2014.196910.1166/jbn.2014.1969 ↗
18. 10.1053/j.semnuclmed.2009.05.00210.1053/j.semnuclmed.2009.05.002 ↗
19. 10.1186/s13058-015-0634-810.1186/s13058-015-0634-8 ↗
20. Wang T. S. T. · J. Nucl. Med. · 1980 · 21 · 767
21. 10.2147/tcrm.s5836710.2147/tcrm.s58367 ↗
22. 10.1038/boneres.2015.1310.1038/boneres.2015.13 ↗
23. 10.1039/b512310k10.1039/b512310k ↗
24. 10.1021/cm300298n10.1021/cm300298n ↗
25. 10.1016/j.addr.2015.10.00510.1016/j.addr.2015.10.005 ↗
26. 10.1016/j.jorganchem.2013.10.03810.1016/j.jorganchem.2013.10.038 ↗
27. 10.1039/c0dt01396j10.1039/c0dt01396j ↗
28. 10.1186/s13550-016-0161-310.1186/s13550-016-0161-3 ↗
29. 10.1016/j.jddst.2019.01.03610.1016/j.jddst.2019.01.036 ↗
30. 10.1021/jp046274g10.1021/jp046274g ↗
31. 10.3390/molecules1608616510.3390/molecules16086165 ↗
32. 10.1021/jm020971k10.1021/jm020971k ↗
33. 10.1089/thy.2009.021310.1089/thy.2009.0213 ↗
34. 10.1038/nbt.333010.1038/nbt.3330 ↗
35. 10.1021/nl100890d10.1021/nl100890d ↗
36. 10.1038/nnano.2008.23110.1038/nnano.2008.231 ↗